Richard Elledge

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

Jenny C. Chang, Eric C. Wooten, Anna Tsimelzon et al. · The Lancet · 2003 · 885 citations

Life Sciences, Oncology, Pharmacology +16

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

Grazia Arpino, V J Bardou, Gary M. Clark et al. · Breast Cancer Research · 2004 · 869 citations · Full text

Medicine, Cancer Biology, Oncology +14

Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer

D. Craig Allred, Gary M. Clark, Richard Elledge et al. · JNCI Journal of the National Cancer Institute · 1993 · 783 citations

Medicine, Molecular Biology, Oncology +17

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

Valérie‐Jeanne Bardou, Grazia Arpino, Richard Elledge et al. · Journal of Clinical Oncology · 2003 · 757 citations

Medicine, Endocrinology, Oncology +17

Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: Results of a North American Trial

C. Kent Osborne, John Pippen, Stephen E. Jones et al. · Journal of Clinical Oncology · 2002 · 643 citations

Medicine, Oncology, Pharmacology +14